UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors

Frontiers in immunology, 2015-04, Vol.6, p.202-202

2015

Volltextzugriff (PDF)

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival

British journal of cancer, 2019-10, Vol.121 (7), p.545-555

2019

Volltextzugriff (PDF)

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy

Cancers, 2021-10, Vol.13 (19), p.4986

2021

Volltextzugriff (PDF)

Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions

Frontiers in immunology, 2018-06, Vol.9, p.1345

2018

Volltextzugriff (PDF)

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival

Cancers, 2019-07, Vol.11 (7), p.996

2019

Volltextzugriff (PDF)

Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma

PloS one, 2014-09, Vol.9 (9), p.e108414-e108414

2014

Volltextzugriff (PDF)

NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival

The Journal of immunology (1950), 2014-12, Vol.193 (12), p.6192-6206

2014

Volltextzugriff (PDF)

Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients

Cancer research (Chicago, Ill.), 2016-09, Vol.76 (18), p.5326-5336

2016

Volltextzugriff (PDF)

CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients

Breast cancer (Tokyo, Japan), 2022-07, Vol.29 (4), p.618-635

2022

Volltextzugriff (PDF)

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma

Oncoimmunology, 2014-01, Vol.3 (1), p.e27185-e27185

2014

Volltextzugriff (PDF)

Influence of Pain and Discomfort in Stroke Patients on Coping Strategies and Changes in Behavior and Lifestyle

Brain sciences, 2021-06, Vol.11 (6), p.804

2021

Volltextzugriff (PDF)

Abstract LB-195: Bortezomib sensitizes glioblastoma for NK cell immunotherapy

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.LB-195-LB-195

2017

Volltextzugriff (PDF)

Differences in the Immune Response of the Nonmetastatic Axillary Lymph Nodes between Triple-Negative and Luminal A Breast Cancer Surrogate Subtypes

The American journal of pathology, 2021-03, Vol.191 (3), p.545-554

2021

Volltextzugriff (PDF)

How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients’ outcome prediction

Histochemistry and cell biology, 2021-11, Vol.156 (5), p.461-478

2021

Volltextzugriff (PDF)

Abstract 2807: Activated NK cells efficiently kill Glioblastoma through activating receptor-ligand interactions

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2807-2807

2014

Volltextzugriff (PDF)

Abstract LB-332: Purified ex vivo expanded and activated human Natural Killer cells efficiently kill glioblastoma cells in a dose- and donor-dependent manner

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-332-LB-332

2013

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy

Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival

Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma

NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival

Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients

CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma

Influence of Pain and Discomfort in Stroke Patients on Coping Strategies and Changes in Behavior and Lifestyle

Abstract LB-195: Bortezomib sensitizes glioblastoma for NK cell immunotherapy

Differences in the Immune Response of the Nonmetastatic Axillary Lymph Nodes between Triple-Negative and Luminal A Breast Cancer Surrogate Subtypes

How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients’ outcome prediction

Abstract 2807: Activated NK cells efficiently kill Glioblastoma through activating receptor-ligand interactions

Abstract LB-332: Purified ex vivo expanded and activated human Natural Killer cells efficiently kill glioblastoma cells in a dose- and donor-dependent manner

Peritumoral immune infiltrates in primary tumours are not associated with the presence of axillary lymph node metastasis in breast cancer: a retrospective cohort study

Suchergebnisse filtern